Sign In
Buy PAM
$88.32
-0.370 (-0.417%)
At Close: Jul 31, 2026
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio
09:15am, Friday, 09'th May 2025
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.
Are Investors Undervaluing Pampa Energia (PAM) Right Now?
10:45am, Tuesday, 29'th Apr 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
01:00am, Friday, 25'th Apr 2025
Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for devel
3 Utility Stocks Set to Deliver 20%+ Returns in 2025
11:24am, Thursday, 24'th Apr 2025
Utility stocks have long been a favorite for investors who are looking for stability and consistent returns in the current market.
All You Need to Know About Pampa (PAM) Rating Upgrade to Strong Buy
01:00pm, Tuesday, 22'nd Apr 2025
Pampa (PAM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for April 22nd
08:25am, Tuesday, 22'nd Apr 2025
DPMLF, PAM, MTAL, HRTX and BALY have been added to the Zacks Rank #1 (Strong Buy) List on April 22, 2025.
Best Value Stocks to Buy for April 22nd
05:10am, Tuesday, 22'nd Apr 2025
AES, PAM and DPMLF made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 22, 2025.
Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies
09:00am, Thursday, 17'th Apr 2025
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate chro
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
01:00am, Thursday, 17'th Apr 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of
Pampa Energia Informs that it has Filed its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
12:30pm, Wednesday, 16'th Apr 2025
BUENOS AIRES, AR / ACCESS Newswire / April 16, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP) (‘Pampa' or the ‘Company'), one of the leading energy companies in Argentina
5 Bargain Picks With Low Price-to-Sales Ratios & High Upside Potential
08:35am, Wednesday, 16'th Apr 2025
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, PCB, ROCK, PRAA and PAM hold promise.
Pampa Energia: Strategic Infrastructure With Latent Upside
06:56am, Tuesday, 15'th Apr 2025
Pampa Energía, Argentina's leading energy firm, shows strong growth in electricity generation and gas production, with significant investments in Vaca Muerta and a new wind power project. Despite a 5
Here's Why You Should Add Pampa Energia Stock to Your Portfolio Now
08:45am, Monday, 07'th Apr 2025
PAM makes a strong case for investment, given its growth prospects, strong ROE, better debt management and focus on clean power generation.
Is Pampa Energia (PAM) Stock Undervalued Right Now?
10:46am, Friday, 04'th Apr 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Marvell to Demonstrate Industry's First 400G/lane PAM4 Electrical-to-Optical Link Technology at OFC 2025
09:00am, Monday, 31'st Mar 2025
Marvell ® 400G Technology is an Industry Breakthrough Enabling a New Generation of PAM4 Network Connectivity SANTA CLARA, Calif. , March 31, 2025 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MR
